FDA Inspection 927833 — BLI International, Inc.

BLI International, Inc. — FEI 3001195380

The FDA completed an inspection of BLI International, Inc. on June 2, 2015 in Deer Park, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 9 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 2, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Deer Park, NY (United States)

Citations

IDCFRDescription
109821 CFR 211.22(c)Approve or reject procedures or specs
110521 CFR 211.22(d)Procedures not in writing, fully followed
111221 CFR 211.25(a)Training--operations, GMPs, written procedures
140921 CFR 211.42(c)(4)In-Process Material Area
154021 CFR 211.125(a)Strict control not exercised over labeling issued
200921 CFR 211.188Prepared for each batch, include complete information
360321 CFR 211.160(b)Scientifically sound laboratory controls
434221 CFR 211.142(b)Storage under appropriate conditions
438221 CFR 211.198(b)(2)Written record of complaint to include findings, follow-up